Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. Aug-Sep 2003;90(8-9):699-705.

[NK Cell-Based Immunotherapy: New Prospects and Involvement of Dendritic Cells]

[Article in French]
Affiliations
  • PMID: 14609759
Review

[NK Cell-Based Immunotherapy: New Prospects and Involvement of Dendritic Cells]

[Article in French]
Christophe Borg et al. Bull Cancer. .

Abstract

Dendritic cells (DC) were initially described as antigen presenting cells able to prime naive T cells. In fact, dendritic cells are also able to activate natural killer (NK) cells. The crosstalk between DC and NK is now regarded as a main stage in the initiation of innate and adaptative immune responses. Moreover, DC mediated-NK cell activation is particularly efficient since DC promote both effector functions and survival or proliferation of NK cells. Furthermore, recent publications in the field of NK cell biology underscore a role for NK cells in anti-tumor effects. NK cell-based immunotherapy should be reconsidered Here, we will report how pioneering immunotherapy trials based on natural cytotoxicity and progress in NK cell biology can promote NK cells in anti-tumor immune responses. Then, we will discuss the biological features of the DC/NK crosstalk and its implementations in immunotherapy protocols.

Similar articles

See all similar articles

Cited by 1 article

MeSH terms

Substances

LinkOut - more resources

Feedback